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Abstract 
Autophagy is a conserved lysosomal degradation pathway that breaks down 
cytoplasmic components and is essential for host cellular immune response. 
The activity of autophagy at a basic rate is crucial for homeostasis. Autophagy 
has emerged in recent years as a major mechanism in many neurodegenerative 
diseases. The regulation of microbial infections and inflammatory responses 
can be significantly influenced by autophagic modulators. In this study, we 
explain the autophagy role as a double-edged sword in anesthesiology and 
critical care. Future studies should focus on investigating the molecular 
mechanism of interplay between pathogen-host-autophagy and on studying 
whether autophagy inducers/inhibitors can exert suitable modulatory 
immunomodulatory effects. Potential organ protection through autophagy 
pathways might be an advantage in patients undergoing anesthesia and/or 






Keywords: Autophagy, Anesthesiology, Viral Infections 
 
Please cite this article as: Zandi M, Fazeli M,  Ghadimi P, Soltani S, Azizi Jalilian F, Banai Shahani A, et al. Autophagy Role as a Double-





Autophagy is a conserved lysosomal 
degradation pathway that breaks down cytoplasmic 
components and is essential for host cellular immune 
response. It is also necessary for cellular survival, 
development, differentiation, and stability (1). 
Three different pathways have been recognized 
for autophagy: macro, chaperon mediated autophagy 
(CMA), microautophagy (2). Autophagy is derived 
from the Greek words “auto” meaning self and 
“phagy” meaning eating and it extensively refers to 
cellular catabolic processes. In autophagy, cytoplasmic 
material is transported to lysosomes for degradation 
(3). Christian De Duve, who won the Nobel Prize for 
his work on lysosomes. The term autophagy was used 
for the first time in 1963. He used the word to describe 
phenomena in which vesicles with single or double-
layer membranes contain the contents (cargo) of the 
cytoplasm, such as organelles for digestion. Thus, 
autophagy can be distinguished from heterophagy that 
cells destroy extracellular material (4). 
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1.1. Types of autophagy 
a. Macroautophagy: macroautophagy is the best well-
characterized pathway of autophagy in which the outer 
membrane of the autophagosome fuses with a 
lysosome to release its components into an 
autolysosome (2). Through activating of several 
regulatory molecules, macroautophagy induces the 
attraction of VP15Lc3 to the autophagosome 
membrane. These regulatory molecules are Beclin 1, 
Vps 34, Ambra1, and Atg 14 (5). 
The selective attraction of mitochondria, which 
is called Mitophagy (a kind of macroautophagy), is 
complex of PTEN – include putative kinase1, P1NK1- 
Parkin, and Bcl2/ adenovirus EIB 19 KD interacting 
protein (Binp3) factor. Lysosomal destruction proteins 
like BAG3 are labeled by polyubiquitin chains and are 
delivered to autophagosome by PG2 scaffold protein 
(5).  
More than 30 genes of ATGs have a role in 
producing materials to form autophagosomes and are 
the main components of the autophagy nucleus (6). 
These are divided into the following groups: 
 Group A consists of ATG9 and its cycling system, 
which includes the ATG1/ULK1 kinase complex 
and ATG2, ATG18 that plays a regulatory role in 
forming autophagosome. 
 Group B including the VPS34 complex 
 Group C contains the ATG8/LC3 and ATG12 
ubiquitin-like protein system, ATG7, ATG10 and 
ATG3, ATG4, ATG5, and ATG16.  
ATG8 takes part in the extension of vesicles. 
ATG8 (ATG7-ATG4-ATG3) complex together with 
LC3 light chain, forms a complex which is necessary 
to form autophagosomes. By induction of autophagy, 
LC3 gets modified, LC3 in mammalian cells is a gold 
standard in autophagic mechanisms (6, 7). 
 
b. Chaperon-Mediated Autophagy (CMA): after the 
damage caused by factors like ROS. Specific 
sequences of amino acids (KF3ZRQ) formed that are 
recognized by HSC70 (heat shock cognate protein70 
KD) in collaboration with LAMP2A (Lysosome-
associated membrane protein2) transports damaged 
proteins to the lysosome (8).  
One of the distinct characteristics of CMA is 
that proteins degraded through this pathway are 
selected in a process, leading to their efficient 
distinguish from their normal neighbors within big 
protein complexes and degrading only the abnormal 
proteins (9).  
Additionally, this selective mechanism allows a 
regulatory role for CMA in multicellular mechanisms 
through participation in the modification of 
intracellular levels of enzymes, replication factors, and 
cell survival proteins. CMA is a process with following 
multiple phases: 
 Substrate recognition and lysosomal targeting 
 Substrate binding and disassembly 
 Substrate transportation 
 Substrate degradation into the lysosomal 
lumen (9). 
 
c. Microautophagy: the direct attraction of small 
proteins from the cytoplasm to a lysosome is called 
microautophagy. This degradation process is generally 
non-selective, lysosomal action and requires the direct 
uptake of cytoplasmic cargoes at a boundary 
membrane by autophagic tubes. The main function of 
microautophagy is to maintain the size of the 
organelles, membrane homeostasis, and cell survival in 
nitrogen scarcity (10). 
The activity of autophagy at a basic rate is 
crucial for homeostasis. Intracellular stresses like viral 
infection trigger autophagy. Depending on the 
environmental conditions, cell type, and virus type, 
autophagy can play a proviral or antiviral role (10, 11). 
During a viral infection, autophagy can detect 
and degrade viruses and their proteins. In autophagy, 
detecting different viruses is not based on a specific 
pattern. The main viral characteristics to detection are 
positive and negative-strand RNA viruses, DNA 
viruses, viral genotypes, viral life cycle, and 
pathogenesis. Cells use this method to prohibit viral 
replication (12, 13). 
Some viruses have adapted approaches to 
escape degradation by lysosomes through autophagy. 
They interfere in the process of autophagy leading to 
their protection within immature lysosomes and use the 
autophagy pathway for their replication.  
Thus, autophagy is a two-edged sword in viral 
infections. Controlling viral replication by regulating 
autophagy is a promising method in the arena of 
antiviral drug discovery (13).  
2. Mechanism and role of autophagy in organisms 
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Autophagy is considered an important survival process 
that keeps the balance of energy sources at important 
stages in development following nutrient stress. It also 
has a role in removing damaged organelles and 
misfolded or accumulated proteins. There is suggesting 
evidence that selective autophagy plays an important 
role in neuropathies, cancer, and heart disease (14). 
Autophagy organizes different aspects of cell 
responses to harmful stimuli like infection (15). 
Researches have shown that autophagy plays a vital 
role in the neonatal period by protecting cells from 
intracellular and extracellular nutrient deficiencies. 
Also, intracellular bacteria can be destroyed by 
autophagosomes. Furthermore, Beclin 1 and PKR 
signaling pathways carry out some of their antiviral 
effects by inducing autophagy. Cytokines responsible 
for intracellular responses to pathogens including IFNs 
and TNFs stimulate autophagy (16, 17). 
 
 
3. The role of autophagy during the life 
3.1. Fetus: eukaryotes have utilized autophagy as an 
evolutionarily conserved pathway to keep cellular 
homeostasis under environmental stress conditions. 
Autophagy plays an important role in the early stages 
of pregnancy including embryogenesis, implantation 
process. Autophagy provides to help extravillous 
trophoblasts which invade the decidua until the first 
third of uterine myometrium and migrate along the 
lumina of spiral arterioles under hypoxic conditions 
and low-level of nutrients in early pregnancy. Poor 
placentation is related to autophagy inhibition. Studies 
have shown that autophagy in the human placentas is 
not simple and it is a controversial process (18, 19). 
Within 4 hours after fertilization autophagy is 
extremely triggered in fertilized oocytes (20). Since 
oocytes without Atg5 are fertilized, autophagy seems 
to be not essential for folliculogenesis and oogenesis 
(21).  
Along with oocyte-to-embryo transition, 
numerous maternal proteins that remained in oocytes 
are available to zygotes (fertilized embryos), but these 
proteins completely are degraded, and synthesized 
proteins are encoded via the zygotic genome again will 
be translated. Stimulation of autophagy is similarly 
detected in the inner cell mass, recognized as the 
pluralist or embryoblast that will evolutionally cause 
the perfect structure of the fetus (22). 
 
3.2. Newborn: autophagy is activated soon after birth 
in neonatal tissues; neonatal tissues may be affected by 
other functions of autophagy. Autophagy can play a 
key role to supply amino acids in response to 
starvation. Besides, this process has a role in 
programmed cell remodeling, glycogen degradation, 
and response to oxidative stress at birth. In newborn 
animals, glucagon secreted during postnatal 
hypoglycemia induces the autophagy process, 
parenteral glucose and insulin can suppress this 
process, which abolishes glucagon secretion (23). At 
the time of birth, the extra-placental food source is 
suddenly lost; hence, neonates are facing starvation 
until the nutrient source can be altered to milk supply. 
The measurement of autophagy along with the 
embryogenesis is low; although after birth, autophagy 
will be upregulated in different tissues and will be at 
high levels for 3–12 h before downregulation to basal 
levels during 1–2 days (24). Animal models that lack 
Atg5 (Atg5, which is vital for autophagosome 
formation) appear to be normal from birth but die 
within a day of birth. These results suggest that the 
degradation of "native" proteins by the process of 
autophagy produces amino acids as an energy source, 
and thus autophagy helps maintain cell homeostasis 
(23). 
 
3.3. Children: some neurological signs in children 
such as developmental delay and neurodegeneration 
may be caused by genetic disorders of autophagy 
during nervous system development in childhood-
onset disorders. The pathological features of different 
childhood neurodegenerative diseases may be caused 
by defective autophagy as a key agent, which leads to 
the accumulation of abnormal protein and 
dysfunctional organelle (25). There is much evidence 
for the developing relationship between autophagy 
dysregulation and lysosomal storage syndromes 
including Lafora disease, Niemann–Pick type C, and 
leukodystrophies such as Alexander disease. 
Furthermore, studies are suggesting the role of 
genetically autophagy dysfunction in Vici syndrome. 
Interestingly knowing the particular mechanism that 
autophagy is linked to disease pathology can give us a 
novel therapeutic way to treat neurodegeneration (26).  
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3.4. Adult: the autophagy process has important roles 
in neurogenesis in several areas of the embryonic 
forebrain. Basal autophagy controls Notch and Wnt 
signaling that is required for adequate neuronal 
differentiation. The studies in the adult show that the 
autophagy-lysosomal pathway controls adult NSC 
maintenance, the activation of quiescent NSCs, the 
timing of their maturation, and the survival of the 
newly born neurons (27). In hematopoietic stem cells, 
losing the autophagy triggers the growth of 
mitochondria and a stimulated metabolic situation that 
enhances regenerative capacity with aging, myeloid 
differentiation, and self-renewal in damaged cells (28). 
There are many questions about NSC, including how 
the dynamics of metabolic pathways and mitochondria 
are closely related to various progressive steps in adult 
neurogenesis (29-31). In this regard, dysregulation of 
mitochondrial structure will be harmful to NSC self-
renewal, with resulting age-dependent reduction and 




4. The role of anesthetic drugs in autophagy 
Anesthetic agents make patients feel comfortable and 
make better conditions for surgical and procedural 
interventions. These agents, both volatile and 
intravenous, are shown to modulate autophagic flux by 
recycling and degrading excess, aged, or dysfunctional 
proteins, maintains tissue homeostasis (33). Ethanol is 
recognized as containing both N-methyl- D-aspartate 
antagonist and γ-Aminobutyric acid agonist features as 
usual applied fugacious anesthetic agents. The latest 
evidence revealed that autophagy may decrease the 
progress of ethanol-stimulated neurotoxicity (34). 
However, it is not always clear, unlike apoptosis, 
whether upregulated autophagy is good or bad. 
Anesthetic autophagy modulation is useful in the vast 
majority of studies, including in vitro and in vivo 
studies. The only study where this was not the case was 
Kashiwagi’s. In this study has been shown that general 
anesthesia can result in a long-term disorder of both 
synaptic transmission and mitochondrial 
morphogenesis in the growing rat brain and muscle-
wasting conditions that are induced via facilitated 
autophagy. Autophagy can have a key part in general 
anesthetic-induced neurotoxicity (35). 
In a study, Qiaoling et al reported that a 
protective effect against myocardial IRI is produced by 
sufentanil pretreatment via regulating miR-
125a/DRAM2 signaling axis (36). In another study, it 
was shown that in vivo model, the creation of 
autolysosome and autophagosome is decreased by 
exposing rat or PC12 cells to propofol PC12 (37). 
Cue et al showed that I/R-stimulated activation 
of autophagy is decreased by propofol. Propofol 
protects cells via blocking autophagy by microRNA 
expression induction  (38). In 2016, Zho et al reported 
that sevoflurane can induce autophagy via endoplasmic 
reticulum stress in H4 cells (39). It also showed that 
autophagic flux can increase by local anesthetics which 
induce neurotoxicity (40). The proliferation of 
damaged cells by hypoxia-reoxygenation via 
remifentanil also can increase autophagy activity in 
human keratinocytes (33).  
Xiong et al in a study (2019) indicated that the 
long noncoding RNA-miRNA-mRNA axes as 
potential therapies can affect the outcome of 
myocardial ischemia-reperfusion injury by regulating 
autophagy, apoptosis, oxidative stress, energy 
metabolism, and the inflammatory response (41). 
 
 
5. The role of autophagy in critical care 
In the severe stage of critical illness, autophagy 
appears to have a distinct function to produce vital 
nutrients to remain cellular integrity. Clinical trials 
show that nutritional support in early steps might 
inhibit the induction of autophagy in patients critically 
ill causing the development of organ failure. However, 
the regulation of autophagy by nutrients, in critical 
illness is not largely clear. Autophagy is a proteolytic 
process that can be activated by oxidative stress, which 
has the potential to either mitigate or exacerbate 
ventilator-induced diaphragmatic dysfunction. 
Weakness and atrophy of the diaphragm muscle are 
related to mechanical ventilation, which named 
ventilator-induced diaphragmatic dysfunction (VIDD). 
Some studies showed that mechanical ventilation can 
induce autophagy and this process cannot lead to 
diaphragmatic weakness. On the other hand, a study 
showed that an increase in the autophagy flux was 
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linked to lower serum levels of non-essential amino 
acids. Therefore, quick nutrition at the beginning of 
critical disease may not inhibit autophagy but can 
reduce the valuable influence of starvation on the 
reactivation of the autophagy mechanism. This can be 
of critical status in the patients, in which this pathway 
is suppressed through critical illness (42). 
 
5.1. Autophagy and virus infection: depending on the 
species, viruses can either take over the autophagy for 
their replication or express certain proteins to suppress 
autophagy (43). Most of the negative-strand RNA (NS-
RNA) viruses use autophagy for replication (44). 
Nevertheless, viral infections trigger autophagy and 
viral constituents are sequestered in autophagosomes. 
In addition to viral degrading, xenophagy indorses 
detection of the pathogen-associated molecular 
patterns (PAMPs) by pattern recognition receptors 
(PRRs) which further results in IFN responses and 
production of proinflammatory cytokines (17). 
a. Autophagy and HIV-1 infection: the virus genome 
inserts in host chromosomes are the main challenge for 
HIV-1 eradication and treatment of the disease. Human 
immunodeficiency virus (HIV) persistence occurs in 
long-lived cells including liver stem cells, CD4 + T 
memory cells, endocrine cells, and monocyte-
macrophage cells such as microglial cells, which are 
the main HIV reservoirs in the central nervous system 
(CNS). Viral latency is usually able to reactivate viral 
infection. This ability is an important mechanism for 
the stability and escape of the virus from detection by 
the immune system (45). 
Autophagy has multiple functions in immunity. 
In addition to its destructive function, the autophagy 
 
Figure 1. Propofol cytoprotective mechanisms via blocking autophagy by microRNA induction. mRNA: Messenger RNA, 
miRNA: microRNA, primiRNA: primary microRNA, premiRNA: precursor microRNA, METTL3: methyltransferase-like 
3, DGCR8: DiGeorge critical region 8, ULK1: Unc-51-like kinase 1. 
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pathway has a role in primary immunity; microbial and 
viral agents are delivered to the PRR receptor of the 
immune cells of macrophages and DCs by the 
autophagy pathway. Autophagy also regulates 
inflammation (46). For example, before inflammation, 
autophagy induces the secretion of IL-1B cytokine 
from macrophages. In T lymphocytes, autophagy 
contributes to present antigens by MHC type II of 
macrophages and DCs and affects the polarization of T 
cells (47). Recent studies have shown that autophagy, 
as an antiviral immune system is an important process 
in the HIV-1 infection cycle (48). HIV uses autophagy 
to facilitate the processing of viral proteins and the 
formation of the virus (48). Besides, autophagy is an 
intracellular degradation process and is responsible for 
clearing out the complex of proteins that cause 
neurodegenerative diseases such as Parkinson's and 
Alzheimer's (49). Therefore, non-regulated autophagy 
in HIV infection causes neurological disorders 
associated (HAND) with HIV. While autophagy is 
stimulated and continuously in CD4 +T uninfected 
cells, however, autophagy is effectively inhibited at the 
transcriptional level in infected cells by down 
regulated of BECLIN (48). Another study (2004) 
found that uninfected T cells died, due to HIV Env 
binding to co-receptor (50). This study proved that 
CXCR4 induces mTOR pathway activity, which 
subsequently causes phosphorylation and activation of 
p53. Expression of the Bax gene and the initiation of 
the mitochondria death pathway is activated by p53. 
This data suggests that HIV-1 uses different strategies 
to counteract the antiviral effects of autophagy during 
infection (50). For example, the viral protein Vif can 
inhibit autophagy in the early stages of infecting CD4 
+ T cells. Viral protein Nef (Negative Factor) is a 
protein that inhibits autophagy via its interaction with 
BECLIN1 and thus prevents the destruction of HIV-1 
during the maturation stage of infected macrophage 
contamination (51). In dendritic cells, the HIV-1 Env 
protein is said to activate the mTOR pathway, thus 
inhibiting autophagy and transmitting the infection to 
CD4 + T cells (52).  
The secreted form of the Tat proteins is detected 
and suppresses autophagy via Src, AKT, and STAT3 
signaling pathways. Moreover, interleukin 10 (IL-10) 
is stimulated by Tat (53). IL-10 inhibits the initiation 
of autophagy in uninfected macrophages. IFN‐γ 
signaling is dysregulated by Tat protein and suppresses 
autophagy in macrophages. Tat protein inhibits 
phosphorylation of STAT1 and decreases the 
upregulation of LC3B and autophagosome formation. 
Besides, HIV‐Tat restricts mycobacteria capture by 
autophagosomes is restricted via HIV-Tat, so 
providing a suitable environment for opportunistic 
microbes in HIV‐infected individuals (53). 
b. Autophagy and Herpes simplex virus (HSV) 
infection: some reports show that double-stranded 
DNA of HSV can trigger autophagy independent of 
viral replication; however, it is dependent on the 
stimulator of interferon genes (54). Activation of 
STING also can induce an innate immune response to 
the infection (55-57).  
HSV-1 has multiple mechanisms to ensure 
replication and prevent autophagy. The ɣ134.5 protein 
of HSV-1 plays an important role in the replication of 
the virus by preventing the formation of the 
autophagophore. This function is done by binding to 
Beclin-1 and by preventing the shutting down of the 
host translation (58-60). The virus also prevents 
autophagy by downregulating the major autophagy 
proteins, sequestome 1 (p62/SQSTm1), and 
optineurin. Furthermore, other ways of preventing 
autophagy have been suggested; Us11 expression can 
inhibit protein kinase R (PKR) and prevent shutting 
down of host translation(61, 62). Besides, protein 
kinase R-like endoplasmic reticulum kinase (PERK) is 
inhibited by glycoprotein B of the virus. Additionally, 
mechanisms that block the innate immune responses 
might inhibit autophagy indirectly (63, 64). 
c. Autophagy and Influenza virus infection: 
autophagy is one of the essential steps in influenza 
virus replication. Influenza infection increases the 
formation of autophagosomes and the autophagy flux. 
Bafilomycin (Baf-A1) is one of the specific proton 
pump inhibitors (V-H + Vacuole), which probably 
affects on acidification of endosomes and ultimately 
has a key role in the replication of the influenza virus 
(59, 60). The use of Baf-A in low doses inhibits 
influenza viruses, which is done by stimulation of 
autophagy by increasing LC3-II. Autophagy can 
restrict virus replication, therefore; it can act as a 
primary immune mechanism. Autophagy suppression 
in viral infection can be a mechanism to escape from 
the immune system by influenza A virus. Ensuing the 
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disruption of the viral escape mechanism from the 
immune system, replication, and virulence of the virus 
decrease. Degradation of autophagosomes during viral 
infection can decrease the replication of the virus in the 
infected cells (65). Autophagy also acts as a key 
mechanism for inflammatory responses from H1N1 
and H9N2. The protein EPG5 (Ectopic P-Granules 
Autophagy Protein 5 Homolog) is essential for 
autophagy and regulates the function of the ATG gene 
complex in the formation of autophagy and expression 
of multiple cytokines in the lung (66). The lacking 
EPG5 in myeloid cells in the lung causes increased IL-
6, IL-1b, and IL-13 cytokine proteins in the lung 
macrophages, which results in favorable cytokine 
levels having protective effects on viral replication, 
and therefore increases the immune response to 
influenza. One study showed that the activation of the 
PI3K/AKT pathway associated with the autophagy 
process has a mutual effect on the replication of the 
influenza virus. Autophagy deficiency leads to 
impaired survival of memory CD8+ T cells during 
influenza virus infection. Secondary apoptosis and 
highly induced autophagy are observed in the influenza 
virus-infected cells (67). 
d. Autophagy and Rabies Virus infection: in vitro 
studies have shown that rabies virus (RABV) infection 
can increase the amount of autophagy and the 
autophagosome buildup. It has also been suggested that 
RABV may prevent cell apoptosis in neuroblastoma 
cell lines (68-70). However, autophagy is not 
completed because of the inhibition of autophagy flux. 
One of the factors affecting this process is the viral 
phosphoprotein 5 (P5) that has multiple functions and 
is involved in viral transcription and replication. P5 
binds to Becline1 (BECN1) and causes the reduction 
of caspase 2 and the stimulation of the AMP-activated 
protein kinase (AMPK)-AKT-mTOR and the 
AMPKmitogen-activated protein kinase pathways (68, 
71). 
It is suggested that the rhabdoviral 
glycoproteins can induce autophagy in vertebrate hosts 
after immunization. Autophagy in this case along with 
other immune responses can cause a long-lasting 
antiviral immune response. However, more research is 
needed to elucidate the role of viral glycoproteins in 
autophagy (72, 73). 
e. Autophagy and Hepatitis C virus (HCV) 
infection: HCV RNA is transferred into the 
endoplasmic reticulum (ER). Non-structural proteins, 
NS4B and NS5A which are encoded by the HCV 
genome have a key role in viral replication and 
host cellular immune response modulation (74). 
Moreover, NS4B protein induces stress response and 
acts as a causative factor of autophagy. Although the 
formation of initial membranous webs to translate 
RNAs is inducted by autophagy, however, these 
structures are not essential for the initial replication of 
HCV RNA (75). There are many indications of indirect 
stimulation of autophagy by HCV infection. The 
accumulation of defective proteins in the endoplasmic 
reticulum (ER) stimulates the stress of the ER. 
Subsequently, stimulating ER stress activates three 
different signaling pathways within the cell. 
1. IRE1 enzyme Pathway 
2. ATF6 Pathway 
3. PERK Pathway 
These three pathways are used to deal with 
defective proteins by cells. This process is called 
"unfolded protein response". During this process, 
protein synthesis decreases in the ER, Protein folding 
is improved by increased regulation of the ER 
chaperone proteins, Increased protein degradation 
through autophagy, and ERAD6 pathway 
(degeneration is dependent on (ER)) (76). The 
apoptosis pathway can stimulate if the UPR pathway 
does not reduce ER stress. Also, ER calcium released 
through ER stress ER leads to deficiency in 
mitochondrial activity and increased production of 
oxygen free radical (ROS) (77). 
HCV increases the expression of PINK1 and 
Parkin (ubiquitin-ligases (E3), Parkin recruits 
substrates to stimulate mitophagy. HCV can reduce 
apoptosis by stimulating mitophagy. PERK is the main 
stimulant of the ATG6 pathway, which increases the 
expression of ATG12 and LC3. Increased autophagy 
and mitophagy is required to maintain survival infected 
cell in chronic infection. Autophagy selectively 
reduces the receptor function of a chain of type 1 
interferon (IFN-α) in response to chronic HCV 
infection, ENT1, and CNT1 Nucleoside analogs 
carriers expression reduced by activation of autophagy, 
Therefore, probably, autophagy is involved in a 
mechanism of resistance to HCV through the IFN-α + 
RBV complex (75, 78). 
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f. Autophagy and Hepatitis B virus (HBV) 
infection: Hepatitis B Virus (HBV) is an enveloped 
DNA virus and a member of the hepadnaviridae 
family. It can cause acute and chronic hepatitis in 
mammals (79). Worldwide, it is responsible for the 
majority of chronic hepatitis. Furthermore, chronic 
HBV infection is the major cause of hepatocellular 
carcinoma (HCC)(80).  
HBV is known to induce autophagy through 
several mechanisms for promoting its replication. X 
protein (HBx) can give rise to autophagosome 
formation. One of the pathways responsible is the class 
3 phosphatidylinositol 3-kinase (PI3KC3)/beclin1 
complex dependent pathway (81). Another pathway is 
considered the increase in ROS production resulting in 
the activation of JNKs and stimulation of 
autophagosome formation (81, 82). The intracellular 
HBV small surface protein (SHB) has been shown to 
stimulate autophagy. Despite HBx it does not affect the 
expression of Beclin 1 and carries its effect by 
triggering ER stress and unfolding protein responses 
(UPR) (82, 83).  
HBV-induced autophagy is known to have a 
strong correlation with hepatocellular carcinoma 
(HCC). An increase in autophagy can increase 
autophagic cell death, anti-tumor immune response, 
and the degradation of oncogenic microRNAs, thus 
weakening tumor progression. Besides, a considerable 
decrease in the amounts of beclin 1 mRNA has been 
seen in HBV-induced HCC cells compared with 
chronic hepatitis B infected cells (82). 
g. Autophagy and Rotavirus infection: rotavirus 
infections are responsible for the majority of 
gastroenteritis in children less than 5 years of age. The 
infection can cause diarrhea, vomiting, malaise, and 
fever (84). The rotavirus is a none-enveloped virus and 
its genome consists of 11 segments of double-stranded 
RNA (dsRNA) (85, 86). Rotavirus is known to induce 
autophagy to the benefit of viral replication. The viral 
non-structural protein NSP4 is an endoplasmic 
reticulum (ER) transmembrane glycoprotein that acts 
as an ion channel and releases ER calcium into the host 
cell cytoplasm. The disruption of calcium homeostasis 
triggers a signaling pathway involving 
Ca2+l/calmodulin protein-dependent kinase kinase2 
(CAMKK2) and the activation of adenosine 
monophosphate-activated protein kinase (AMPK) 
which induces autophagy (87, 88). Evidence suggests 
that the NSP4 molecule on the COPII vesicles interacts 
with autophagy protein LC3 and along with viral 
protein VP7 traffic to viroplasms, the immature virus 
particles then interact with NSP4 and bud through the 
membrane and form the infectious particles (89). 
Another mechanism affecting autophagy is used by 
rotaviruses in which cellular microRNAs are 
manipulated to induce autophagy; this is done by 
enhancing miR-99b expression and reducing let-7g 
expression (90). Besides, some of the rotaviruses 
encoded virus-like small RNA1755 triggers autophagy 
by inhibition of the PI3K/Akt/mTOR pathway; 




In the development and progression of 
neurodegenerative diseases, protein degradation 
pathways play a key role. Autophagy has emerged in 
recent years as a major mechanism in many 
neurodegenerative diseases. A greater understanding 
of the role of autophagy in many diseases, including 
common neurodegenerative diseases such as 
Alzheimer's or Parkinson's, has led to an interest in 
pharmacological-based or gene therapy approaches to 
modify autophagy. Besides, this system has some 
adventitious and pitfall in combat against viruses. 
The pathway has raised many hopes as a 
therapeutic goal due to the essential role of autophagy 
in the immune response. The regulation of microbial 
infections and inflammatory responses can be 
significantly influenced by autophagic modulators. 
Future studies should focus on investigating the 
molecular mechanism of interplay between pathogen-
host-autophagy and on studying whether autophagy 
inducers/inhibitors can exert suitable modulatory 
immunomodulatory effects. Also, to evaluate drug 
efficacy and kinetics in patients, accurate biomarkers 
for autophagy measurement are needed. 
There may be some potential approaches to take 
advantage of autophagy pathways to reach therapeutic 
goals in the field of organ protection; these potential 
approaches might be beneficial for patients undergoing 
anesthesia and/or needing critical care. 
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